Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FEMLYV™ safely and effectively. See full prescribing information for FEMLYV. FEMLYV (norethindrone acetate and ethinyl estradiol orally disintegrating tablets)Initial U.S. Approval: 1968
Medication labelWhy this: Advisory · dailymed-prescription
FEMLYV is indicated for use by females of reproductive potential to prevent pregnancy [see Clinical Studies (14)]. Limitations of Use The efficacy of FEMLYV in females with a body mass index (BMI) of more than 35 kg/m2 has not been evaluated.
- generic_name
- norethindrone acetate/ethinyl estradiol
- brand_name
- placebo
- product_names
- Norethindrone Acetate/Ethinyl Estradiol, placebo
- ndc
- 72495-601, 72495-601-84, 72495-601-28, 72495-241, 72495-502
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en